Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 88
Filter
1.
Exp Dermatol ; 29(2): 118-123, 2020 02.
Article in English | MEDLINE | ID: mdl-31519056

ABSTRACT

Hidradenitis suppurativa (HS) tunnels and Crohn's disease (CD) fistulas are a challenge to treat. Although pathogenic similarities have been described between HS and CD, recent studies indicate that clinical, microbiological, immunological and imaging characteristics differ between these diseases. This review highlights the differences between HS tunnels and CD fistulas. Next-generation sequencing studies demonstrate a microbiome in HS tunnels dominated by Porphyromonas spp., Prevotella spp. whereas no specific bacteria have been associated with cutaneous CD. Immunologically, TNF has been found upregulated in HS tunnels along with various interleukins (IL-8, IL-16, IL-1α and IL-1ß). In CD fistulas, Th1, Th17, IL-17, IFN-ɤ, TNF and IL-23 are increased. US imaging is an important tool in HS. US of HS tunnels depict hypoechoic band-like structure across skin layers in the dermis and/or hypodermis connected to the base of a widened hair follicle. In CD, MR imaging of simple perianal fistulas illustrates a linear, non-branching inflammatory tract relating to an internal opening in the anus or low rectum and an external opening to the skin surface. An increased awareness of the immediate potential differences between HS tunnels and CD fistulas may optimize treatment regimens of these intractable skin manifestations.


Subject(s)
Crohn Disease/complications , Cutaneous Fistula , Cytokines/metabolism , Hidradenitis Suppurativa , Rectal Fistula , Cutaneous Fistula/diagnostic imaging , Cutaneous Fistula/immunology , Cutaneous Fistula/microbiology , Cutaneous Fistula/pathology , Hidradenitis Suppurativa/diagnostic imaging , Hidradenitis Suppurativa/immunology , Hidradenitis Suppurativa/microbiology , Hidradenitis Suppurativa/pathology , Humans , Leukocytes , Magnetic Resonance Imaging , Microbiota , Rectal Fistula/diagnostic imaging , Rectal Fistula/immunology , Rectal Fistula/microbiology , Rectal Fistula/pathology , Ultrasonography
2.
Eur Spine J ; 29(7): 1467-1473, 2020 07.
Article in English | MEDLINE | ID: mdl-29923018

ABSTRACT

Although total disc arthroplasty (TDA) is a common procedure for selected cases of degenerative disc disease, until today there are only two cases of TDA infections reported in the literature. We report three cases of postoperative TDA infections, two developed cutaneous fistulas. To eradicate the infectious site, a staged removal of the device, resolute debridement, and stabilization plus fusion is proposed. Surgeons are challenged by (1) major retroperitoneal vessels adherent to the device, (2) surrounding scar tissue, (3) accompanying retroperitoneal abscess, and (4) technical issues when removing and replacing the implant. A staged multidisciplinary team approach involving vascular and plastic surgery as well as spine specialists is mandatory to achieve good results.


Subject(s)
Arthroplasty/adverse effects , Intervertebral Disc , Prosthesis-Related Infections/surgery , Spinal Fusion , Total Disc Replacement , Adult , Anti-Bacterial Agents/therapeutic use , Cutaneous Fistula/drug therapy , Cutaneous Fistula/etiology , Cutaneous Fistula/microbiology , Cutaneous Fistula/surgery , Debridement , Device Removal , Female , Humans , Intervertebral Disc/surgery , Joint Prosthesis/adverse effects , Lumbar Vertebrae/surgery , Male , Middle Aged , Patient Care Team , Prosthesis-Related Infections/drug therapy , Prosthesis-Related Infections/etiology , Prosthesis-Related Infections/microbiology , Spinal Fusion/methods , Staphylococcal Infections/drug therapy , Staphylococcal Infections/etiology , Staphylococcal Infections/microbiology , Staphylococcal Infections/surgery , Total Disc Replacement/adverse effects , Treatment Outcome
3.
Int Wound J ; 17(1): 187-190, 2020 Feb.
Article in English | MEDLINE | ID: mdl-31663272

ABSTRACT

Pyoderma gangrenosum is an uncommon ulcerative cutaneous lesion manifesting as rapidly progressing single or multiple skin ulcers. Permanent stoma in inflammatory bowel disease patients remains an independent risk of pyoderma gangrenosum. In the current report, we describe a case of pyoderma gangrenosum in a post-colostomy ulcerative colitis patient with chronic hepatitis B. Pyoderma gangrenosum began seemingly as peristomal dermatitis that rapidly developed into painful ulcerations with subsequent appearance of sterile pustules and ulcerations in the left lower leg. The patient significantly improved after active management with prednisolone, antiviral therapy with entecavir, and wound dressings. Our case suggests that physicians and surgeons should have a high index of suspicion of pyoderma gangrenosum in post-colostomy ulcerative colitis patients who develop peristomal dermatitis.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Colitis, Ulcerative/surgery , Colostomy/adverse effects , Cutaneous Fistula/complications , Hepatitis B, Chronic/complications , Pyoderma Gangrenosum/drug therapy , Pyoderma Gangrenosum/etiology , Adult , Cutaneous Fistula/microbiology , Humans , Male , Treatment Outcome
4.
J Vasc Surg ; 68(6): 1906-1913.e1, 2018 12.
Article in English | MEDLINE | ID: mdl-29685511

ABSTRACT

OBJECTIVE: After primary infection with Coxiella burnetii, patients may develop acute Q fever, which is a relatively mild disease. A small proportion of patients (1%-5%) develop chronic Q fever, which is accompanied by high mortality and can be manifested as infected arterial or aortic aneurysms or infected vascular prostheses. The disease can be complicated by arterial fistulas, which are often fatal if they are left untreated. We aimed to assess the cumulative incidence of arterial fistulas and mortality in patients with proven chronic Q fever. METHODS: In a retrospective, observational study, the cumulative incidence of arterial fistulas (aortoenteric, aortobronchial, aortovenous, or arteriocutaneous) in patients with proven chronic Q fever (according to the Dutch Chronic Q Fever Consensus Group criteria) was assessed. Proven chronic Q fever with a vascular focus of infection was defined as a confirmed mycotic aneurysm or infected prosthesis on imaging studies or positive result of serum polymerase chain reaction for C. burnetii in the presence of an arterial aneurysm or vascular prosthesis. RESULTS: Of 253 patients with proven chronic Q fever, 169 patients (67%) were diagnosed with a vascular focus of infection (42 of whom had a combined vascular focus and endocarditis). In total, 26 arterial fistulas were diagnosed in 25 patients (15% of patients with a vascular focus): aortoenteric (15), aortobronchial (2), aortocaval (4), and arteriocutaneous (5) fistulas (1 patient presented with both an aortocaval and an arteriocutaneous fistula). Chronic Q fever-related mortality was 60% for patients with and 21% for patients without arterial fistula (P < .0001). Primary fistulas accounted for 42% and secondary fistulas for 58%. Of patients who underwent surgical intervention for chronic Q fever-related fistula (n = 17), nine died of chronic Q fever-related causes (53%). Of patients who did not undergo any surgical intervention (n = 8), six died of chronic Q fever-related causes (75%). CONCLUSIONS: The proportion of patients with proven chronic Q fever developing primary or secondary arterial fistulas is high; 15% of patients with a vascular focus of infection develop an arterial fistula. This observation suggests that C. burnetii, the causative agent of Q fever, plays a role in the development of fistulas in these patients. Chronic Q fever-related mortality in patients with arterial fistula is very high, in both patients who undergo surgical intervention and patients who do not.


Subject(s)
Aneurysm, Infected/microbiology , Arteriovenous Fistula/microbiology , Bronchial Fistula/microbiology , Bronchial Fistula/surgery , Cutaneous Fistula/microbiology , Endocarditis, Bacterial/microbiology , Intestinal Fistula/microbiology , Prosthesis-Related Infections/microbiology , Q Fever/microbiology , Aged , Aged, 80 and over , Aneurysm, Infected/diagnosis , Aneurysm, Infected/mortality , Aneurysm, Infected/surgery , Arteriovenous Fistula/diagnosis , Arteriovenous Fistula/mortality , Arteriovenous Fistula/surgery , Bronchial Fistula/diagnosis , Bronchial Fistula/mortality , Cutaneous Fistula/diagnosis , Cutaneous Fistula/mortality , Cutaneous Fistula/surgery , Endocarditis, Bacterial/diagnosis , Endocarditis, Bacterial/mortality , Endocarditis, Bacterial/surgery , Female , Humans , Incidence , Intestinal Fistula/diagnosis , Intestinal Fistula/mortality , Intestinal Fistula/surgery , Male , Middle Aged , Netherlands/epidemiology , Prognosis , Prosthesis-Related Infections/diagnosis , Prosthesis-Related Infections/mortality , Prosthesis-Related Infections/surgery , Q Fever/diagnosis , Q Fever/mortality , Q Fever/surgery , Registries , Retrospective Studies , Risk Factors , Time Factors
5.
Urologia ; 85(1): 38-40, 2018 Feb.
Article in English | MEDLINE | ID: mdl-29619903

ABSTRACT

INTRODUCTION: We present a case of a spongiosus-cutaneous fistula in a 39-year-old man with recurrent episodes of cutaneous abscess in dorsal middle third penis (5 × 3 cm) treated with Hyperbaric Oxygen Therapy (HBOT). CASE REPORT: After emptying nodular abscess, the patient was noncompliant for further surgery. Therefore, it was suggested the association between HBOT and antibiotic therapy. HBOT is carried out in a hyperbaric room, where the internal pressure is increased (compression phase) by entering compressed air up to 283.71 kPa in about 10 minutes. Every HBOT cycle lasted 24 days in which the patient had been taking Amoxicillin/Clavulanic Acid 875 mg/125 mg 3 tabs/day and Sulfamethoxazole/Trimethoprim 160 mg/800 mg 2 tabs/day for 2 weeks. At the end of the treatment, a penile magnetic resonance imaging and an ultrasonography were executed and they evidenced a complete remission of the lesion. In the subsequent 22 months, there was no recurrence. CONCLUSIONS: Our results suggest that HBOT is an effective treatment for chronic wounds, including a spongiosus-cutaneous fistula of unknown cause, when used in combination with conventional standard therapy or further interventions. At present time, the gold standard remains surgery; nevertheless, our experience with HBOT may stimulate its use in clinical trials.


Subject(s)
Abscess/complications , Cutaneous Fistula/etiology , Cutaneous Fistula/therapy , Hyperbaric Oxygenation , Penis , Abscess/microbiology , Adult , Cutaneous Fistula/microbiology , Cutaneous Fistula/pathology , Humans , Hyperbaric Oxygenation/methods , Male , Penis/microbiology , Treatment Outcome , Wound Healing
8.
Ann Vasc Surg ; 39: 291.e1-291.e6, 2017 Feb.
Article in English | MEDLINE | ID: mdl-27903467

ABSTRACT

Vascular complications of intravesical instillation of bacillus Calmette-Guérin (BCG) are rare. BCG is an attenuated strain of Mycobacterium bovis that was initially developed for vaccination against tuberculosis, but it has also been used as an adjuvant treatment for bladder transitional carcinoma. We report a patient with a history of instillation of BCG 2 years before, who underwent surgical treatment of 2 pseudoaneurysms. The first, located in the left superficial femoral artery (SFA), was resected, and the artery was ligated because he had a history of femoropopliteal occlusion. After 4 weeks, he presented another one associated with hemorrhage by cutaneous fistula, in the right common femoral artery. In this case, revascularization was performed by means a common-to-deep femoral artery bypass with polytetrafluorethylene graft and reimplantation of SFA. Initially, bacterial cultures were negative, but bacilli cultures identified M. bovis after 3 weeks. Antituberculosis therapy was administered. After 13 months, the patient was asymptomatic and duplex ultrasound showed no signs of recurrent infection. This exposure should be considered if presentation of the false aneurysm is spontaneous and there is a history of bladder carcinoma.


Subject(s)
Aneurysm, False/microbiology , Aneurysm, Infected/microbiology , Antineoplastic Agents/adverse effects , BCG Vaccine/adverse effects , Cutaneous Fistula/microbiology , Femoral Artery/microbiology , Mycobacterium bovis/isolation & purification , Urinary Bladder Neoplasms/drug therapy , Vascular Fistula/microbiology , Administration, Intravesical , Aged , Aneurysm, False/diagnostic imaging , Aneurysm, False/surgery , Aneurysm, Infected/diagnostic imaging , Aneurysm, Infected/surgery , Antineoplastic Agents/administration & dosage , Antitubercular Agents/therapeutic use , BCG Vaccine/administration & dosage , Blood Vessel Prosthesis Implantation , Computed Tomography Angiography , Cutaneous Fistula/diagnostic imaging , Cutaneous Fistula/surgery , Femoral Artery/diagnostic imaging , Femoral Artery/surgery , Humans , Ligation , Male , Recurrence , Reoperation , Replantation , Treatment Outcome , Vascular Fistula/diagnostic imaging , Vascular Fistula/surgery
9.
Scand Cardiovasc J ; 50(5-6): 341-348, 2016.
Article in English | MEDLINE | ID: mdl-27102109

ABSTRACT

Surgical site infections (SSIs) are common complications after open heart surgery. Fortunately, most are superficial and respond to minor wound debridement and antibiotics. However, 1-3% of patients develop deep sternal wound infections that can be fatal. Late infections with sternocutaneous fistulas, are encountered less often, but represent a complex surgical problem. This evidence-based review covers etiology, risk factors, prevention and treatment of sternal SSIs following open heart surgery with special focus on advances in treatment, especially negative-pressure wound therapy.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Cardiac Surgical Procedures/adverse effects , Debridement , Negative-Pressure Wound Therapy , Sternotomy/adverse effects , Surgical Wound Infection/prevention & control , Surgical Wound Infection/therapy , Cardiac Surgical Procedures/mortality , Cutaneous Fistula/microbiology , Cutaneous Fistula/therapy , Humans , Reoperation , Risk Assessment , Risk Factors , Sternotomy/mortality , Surgical Wound Infection/microbiology , Surgical Wound Infection/mortality , Time Factors , Treatment Outcome
10.
Rev. Asoc. Odontol. Argent ; 104(1): 38-41, mar. 2016. ilus
Article in Spanish | LILACS | ID: lil-789833

ABSTRACT

Objetivo: diagnosticar y tratar la presencia de una fístula cutánea. Caso clínico: un paciente de sexo masculino, de 9 años de edad, consultó por una lesión cutánea en la zona mandibular del lado izquierdo. Concusiones: una fístula cutánea requiere un diagnóstico diferencial preciso, a fin de determinar su etiología y planificar el procedimiento endodóntico correcto. Como consecuencia de una mortificación pulpar, la presencia de bacterias dentro del conducto radicular puede generar una periodontitis perirradicular crónica de origen endodóntico.


Subject(s)
Humans , Male , Child , Periapical Diseases/complications , Cutaneous Fistula/diagnosis , Cutaneous Fistula/therapy , Diagnosis, Differential , Drainage , Cutaneous Fistula/microbiology , Calcium Hydroxide/therapeutic use , Root Canal Therapy
12.
J Mycol Med ; 25(4): 297-302, 2015 Dec.
Article in French | MEDLINE | ID: mdl-26547231

ABSTRACT

Mycetoma is a bacteriological or fungal infectious disease affecting the skin and/or soft tissues, which can be complicated by bone involvement. The most common feature is a tumor of the foot, but extrapodal localizations have been described. We report one case of a 47-year-old man who presented with tumefaction of a leg with multiple skin fistulae. Histopathological examination permitted to confirm the diagnosis of actinomycetoma and TDM showed the degree of bone and soft tissues involvement. Our case was characterized by the very inflammatory aspect of the tumor, its localization to the leg without foot involvement, the modest functional signs compared to the importance of radiological bone involvements, the deep destruction of the fibula while the tibia was apparently intact and the good response to treatment. In spite of its characteristic features, diagnosis of mycetoma is still late in our country, often with bone and/or articular spread. Priority may be given to measures for reduction of mycetoma diagnosis lateness.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Diclofenac/therapeutic use , Mycetoma/drug therapy , Trimethoprim, Sulfamethoxazole Drug Combination/therapeutic use , Bone Diseases, Infectious/drug therapy , Bone Diseases, Infectious/microbiology , Bone Diseases, Infectious/pathology , Cutaneous Fistula/drug therapy , Cutaneous Fistula/microbiology , Cutaneous Fistula/pathology , Delayed Diagnosis , Humans , Leg/microbiology , Leg/pathology , Male , Middle Aged , Mycetoma/complications , Mycetoma/pathology , Osteolysis/drug therapy , Osteolysis/microbiology , Osteolysis/pathology , Treatment Outcome
13.
Arch Pediatr ; 22(11): 1154-6, 2015 Nov.
Article in French | MEDLINE | ID: mdl-26404894

ABSTRACT

Dysosteosclerosis is a rare genetic disorder with a poor prognosis. It is an osteochondrodysplasia similar to osteopetrosis but it is typically characterized by platyspondyly and expanded metaphyses. It shows complications such as compression of cranial nerves, especially the optic nerve, hematologic complications, fractures following mild injury, abnormal dentition, neurological and psychological deterioration, in addition to osteomyelitis of the mandible. We report a new case of dysosteosclerosis complicated by osteomyelitis of the lower maxilla.


Subject(s)
Mandibular Diseases/microbiology , Osteomyelitis/complications , Osteosclerosis/complications , Child, Preschool , Cutaneous Fistula/microbiology , Female , Humans , Imaging, Three-Dimensional , Osteomyelitis/microbiology , Osteosclerosis/diagnostic imaging , Staphylococcal Infections/complications , Tomography, X-Ray Computed
15.
Pediatr Dent ; 37(1): 70-4, 2015.
Article in English | MEDLINE | ID: mdl-25685977

ABSTRACT

Tuberculosis (TB) can affect almost any organ of the body; however, TB of the salivary glands is a rare condition. The purpose of this paper was to report a case of a 14-year-old boy who presented with a painless swelling and discharging sinus in the parotid gland and cervical region on the left side. There was no clinical evidence of systemic signs and symptoms of active TB elsewhere in the body. The combination of clinical suspicion, a positive family history, and the cytological findings confirmed the diagnosis. The patient was successfully treated via antitubercular therapy for six months. This case report suggests that, although primary TB of the parotid gland is an unusual clinical presentation, it should be considered in the differential diagnosis of patients presenting with a parotid gland swelling.


Subject(s)
Parotid Diseases/microbiology , Tuberculosis, Lymph Node/diagnosis , Tuberculosis, Oral/diagnosis , Adolescent , Antitubercular Agents/therapeutic use , Cutaneous Fistula/microbiology , Humans , Male , Oral Fistula/microbiology , Parotid Diseases/diagnostic imaging , Tuberculin Test , Tuberculosis, Lymph Node/diagnostic imaging , Tuberculosis, Oral/diagnostic imaging , Ultrasonography, Doppler, Color
16.
JAMA Otolaryngol Head Neck Surg ; 140(9): 861-6, 2014 Sep.
Article in English | MEDLINE | ID: mdl-25104080

ABSTRACT

IMPORTANCE: There are limited data on the use of the supraclavicular artery island flap (SCAIF) for parotid and lateral skull base (LSB) surgery. This flap can be an important reconstructive tool for these procedures. OBJECTIVE: To describe the use of the SCAIF for parotid and LSB surgery and its success, as well as important technique modifications for successful use of the flap in this setting. DESIGN, SETTING, AND PARTICIPANTS: Retrospective single-institution review from July 1, 2011, to September 30, 2013, of patients in a tertiary care referral center. A prospectively collected institutional database was reviewed to identify patients who received SCAIF reconstruction for parotid and/or LSB surgery. Forty-six SCAIF reconstructions were identified; 16 were performed for the indication of parotidectomy or LSB surgery. INTERVENTIONS: The SCAIF reconstruction for parotid and/or LSB surgery. MAIN OUTCOMES AND MEASURES: Indication for reconstruction, flap viability, flap size, reconstruction site complication, and donor site complication. RESULTS: Resection was performed for advanced cutaneous malignant tumor in 10 patients, primary salivary gland malignant tumor in 4 patients, and chronic infection and mastoid cutaneous fistula in 2 patients. All defects were complex, involving multiple subsites; 5 patients underwent facial nerve resection and 4 had previous radiation therapy. No complete flap loss occurred. One partial flap loss occurred. The average flap island size was 7 × 10 cm. No major complications occurred. Two minor reconstruction site complications and 3 donor site seromas occurred. CONCLUSIONS AND RELEVANCE: The SCAIF can be successfully and reliably used for complex defects following parotid and LSB surgery. There are 3 important technique modifications to help facilitate rotation and coverage of this region.


Subject(s)
Ear Auricle/surgery , Parotid Gland/surgery , Skull Base/surgery , Surgical Flaps/blood supply , Actinomycosis/surgery , Carcinoma/surgery , Cutaneous Fistula/microbiology , Cutaneous Fistula/surgery , Ear Neoplasms/surgery , Graft Survival , Humans , Mastoid/surgery , Retrospective Studies , Salivary Gland Neoplasms/surgery , Skin Neoplasms/surgery
17.
Tex Heart Inst J ; 41(3): 324-6, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24955054

ABSTRACT

Cutaneous fistula as a clinical presentation of intracardiac abscess of the right side is such an unusual occurrence that it has not until now been reported in the English-language medical literature. We present a rare case of right-sided infective endocarditis caused by Achromobacter xylosoxidans in which recurrent infection presented as sternal wound discharge. The infection was found to have an intracardiac origin and was successfully managed by radical débridement on cardiopulmonary bypass.


Subject(s)
Abscess/microbiology , Achromobacter denitrificans/isolation & purification , Cardiac Surgical Procedures/adverse effects , Cutaneous Fistula/microbiology , Endocarditis, Bacterial/microbiology , Gram-Negative Bacterial Infections/microbiology , Heart Septal Defects, Ventricular/surgery , Surgical Wound Infection/microbiology , Abscess/diagnosis , Anti-Bacterial Agents/therapeutic use , Cardiopulmonary Bypass , Cutaneous Fistula/diagnosis , Cutaneous Fistula/surgery , Debridement , Diagnosis, Differential , Endocarditis, Bacterial/diagnosis , Female , Gram-Negative Bacterial Infections/diagnosis , Gram-Negative Bacterial Infections/surgery , Humans , Middle Aged , Predictive Value of Tests , Recurrence , Reoperation , Surgical Wound Infection/diagnosis , Time Factors , Treatment Outcome , Wound Healing
18.
Arch Pediatr ; 21(7): 757-60, 2014 Jul.
Article in French | MEDLINE | ID: mdl-24935449

ABSTRACT

INTRODUCTION: Actinomycosis is a suppurative infection caused by bacteria of the Actinomyces genus. It is a rare cause of pulmonary infection and can be difficult to diagnose because its presentation may mimic tuberculosis or cancer. In the absence of treatment of pulmonary lesions fistulae can develop. We report a case of thoracic actinomycosis with chest wall involvement in a child, managed in the pediatric department at Moulay Youssef University Hospital in Rabat, Morocco. CASE REPORT: We report the case of a 13-year-old boy with a history of trauma to the right chest 1 year earlier, admitted with right-sided chest wall swelling with cutaneous fistulae. Physical examination identified a parietal mass with fistulization to the skin. Laboratory tests showed an inflammatory syndrome. The chest x-ray revealed moderate right pleural effusion. The thoracic computed tomography scan showed a right parietal pleural mass and the percutaneous biopsy confirmed the diagnosis of actinomycosis. The patient underwent antibiotic therapy with favorable evolution. CONCLUSION: The diagnosis, the clinical, radiological and histological pattern, and the therapeutic features are described in this report.


Subject(s)
Actinomycosis/complications , Cutaneous Fistula/microbiology , Lung Diseases/complications , Pleural Diseases/complications , Thoracic Wall , Actinomycosis/microbiology , Adolescent , Humans , Lung Diseases/microbiology , Male
19.
Indian J Tuberc ; 61(4): 325-30, 2014 Oct.
Article in English | MEDLINE | ID: mdl-25675696

ABSTRACT

AIM: The aim of this study was to evaluate the clinical characteristics of orofacial lesions like ulcer, swelling, discharge (with or without fistulae), nodules (tubercles), granulomatous growth, induration, diffuse inflammation, and extraction socket involvement in an Indian population through the case reports and review of literature. MATERIAL AND METHODS: Four case reports are presented of patients who had orofacial lesions which turned out to be tuberculous. The diagnosis of tuberculosis was possible because it was kept high on the list of differential diagnosis of orofacial lesions. In our study, we used the following clinical criteria: 1) Suspicious lymph nodes should be biopsied. 2) Excision of non-healing, fistulous, or non-responsive lesions should be considered for biopsy. 3) Histopathological evidence of granulomatous inflammation with epithelioid cells and Langhan's giant cells or acid-fast bacilli should on Ziehl-Neelsen staining. 4) The patients' medical records were reviewed for details relating to presenting signs and symptoms, site and appearance of the lesions, chest x-ray findings, and sputum smear and tuberculosis culture results. RESULTS: In all cases, the patients were prescribed antituberculosis therapy (ATT) by the physician. Strict follow-up was done to ensure completion of intensive phase therapy and both oral as well as pulmonary lesions were resolved. CONCLUSION: Dentists and physicians treating orofacial lesions should be alert to the possibility of orofacial tuberculosis. Medical history should be taken very carefully and lymph node biopsy as well as other radiological and microbiological investigations should be carried out to rule out oral tuberculosis. Antituberculous therapy leads to successful resolution of the orofacial lesions.


Subject(s)
Cutaneous Fistula/microbiology , Facial Dermatoses/diagnosis , Osteomyelitis/diagnosis , Tongue Diseases/diagnosis , Tuberculosis, Cutaneous/diagnosis , Tuberculosis, Oral/diagnosis , Adult , Antitubercular Agents/therapeutic use , Facial Dermatoses/drug therapy , Facial Dermatoses/microbiology , Female , Humans , Male , Mouth Mucosa , Osteomyelitis/drug therapy , Osteomyelitis/microbiology , Radiography , Tongue Diseases/drug therapy , Tongue Diseases/microbiology , Tuberculosis, Cutaneous/drug therapy , Tuberculosis, Oral/drug therapy , Tuberculosis, Pulmonary/diagnostic imaging , Tuberculosis, Pulmonary/drug therapy
20.
Pol Orthop Traumatol ; 78: 251-7, 2013 Dec 16.
Article in English | MEDLINE | ID: mdl-24343272

ABSTRACT

BACKGROUND: The growing popularity of arthroplasty results in an increase in the number of infectious complications. The clinical course of inflammation, silent initial symptoms of the disease and non-medical factors, such as poor public awareness and difficulty in finding specialist care, lead patients to postpone the decision about surgical intervention. This results in a state of imminent threat to health or life by endangering other organs of the body. The purpose of this study was to analyze extreme cases of vital organ damage due to infections following hip and knee replacement procedures. MATERIAL AND METHODS: Retrospective analysis of selected cases of life-threatening infectious complications resulting in vital organ damage (urinary tract, large vessels, cardiorespiratory system, etc.) treated at the Department of Orthopedics at the Center of Postgraduate Medical Education (CPME) over the past 12 years. RESULTS: Establishment of an early diagnosis, and above all, confirmation of periprosthetic infection are extremely important. This allows for a biologically reasonable, early and radical management with the best possible treatment options and prevents the risk of life-threatening complications. CONCLUSIONS: Universal access to antibiotics, suppression rather than treatment of infections, silent and unusual course of septic joint loosening and the lack of sufficient awareness of the problem among physicians, contribute to the reoccurrence of such cases and cause significant treatment challenge. They require management at multidisciplinary centers specializing in such cases and rarely end successfully.


Subject(s)
Arthroplasty, Replacement, Hip/adverse effects , Arthroplasty, Replacement, Knee/adverse effects , Enterobacteriaceae Infections/diagnosis , Prosthesis-Related Infections/microbiology , Abscess/microbiology , Aged , Cutaneous Fistula/microbiology , Enterobacter/isolation & purification , Enterobacteriaceae Infections/microbiology , Equipment Failure Analysis , Fatal Outcome , Female , Femoral Neck Fractures/therapy , Humans , Knee Prosthesis/adverse effects , Male , Pseudarthrosis/therapy , Reoperation , Shock, Septic/microbiology
SELECTION OF CITATIONS
SEARCH DETAIL
...